Last reviewed · How we verify
GH21 Capsule
GH21 Capsule is a growth hormone analogue used to treat growth hormone deficiency.
GH21 Capsule is a growth hormone analogue used to treat growth hormone deficiency. Used for Growth hormone deficiency in children.
At a glance
| Generic name | GH21 Capsule |
|---|---|
| Sponsor | Suzhou Genhouse Bio Co., Ltd. |
| Drug class | Growth hormone analogue |
| Target | Growth hormone receptor |
| Modality | Small molecule |
| Therapeutic area | Endocrinology |
| Phase | Phase 2 |
Mechanism of action
GH21 Capsule works by mimicking the action of natural growth hormone in the body, stimulating growth and development in children with growth hormone deficiency. It is administered via injection and has a rapid onset of action.
Approved indications
- Growth hormone deficiency in children
Common side effects
- Injection site reaction
- Headache
- Nausea
Key clinical trials
- A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors (PHASE1, PHASE2)
- Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation (PHASE2)
- GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results (PHASE1)
- GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors (PHASE1, PHASE2)
- A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GH21 Capsule CI brief — competitive landscape report
- GH21 Capsule updates RSS · CI watch RSS
- Suzhou Genhouse Bio Co., Ltd. portfolio CI